HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

2- imino- 5- ((5- (2- nitrophenyl)furan- 2- yl)methylene)thiazolidin- 4- one

improves muscle function by restoring dystrophin expression; structure in first source
Also Known As:
RTC13; read-through compound 13
Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Barquinero, Jordi: 2 articles (01/2020 - 01/2020)
2. Andreu, Antoni L: 1 article (01/2020)
3. Arenas, Joaquin: 1 article (01/2020)
4. Brull, Astrid: 1 article (01/2020)
5. Cortina, Vicente: 1 article (01/2020)
6. Krag, Thomas O: 1 article (01/2020)
7. Lucia, Alejandro: 1 article (01/2020)
8. Martorell, Lluis: 1 article (01/2020)
9. Martín, Miguel Angel: 1 article (01/2020)
10. Moya, Laura: 1 article (01/2020)

Related Diseases

1. Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
2. Hemophilia A (Haemophilia)
3. Glycogen Storage Disease Type V (McArdle's Disease)

Related Drugs and Biologics

1. ataluren
2. antibiotic G 418
3. Nonsense Codon (Nonsense Mutation)
4. Dystrophin
5. Gentamicins (Gentamicin)
6. amlexanox (Aphthasol)